Hong Kong Pharmas Expect City To Attract More MNC Clinical Trials
This article was originally published in PharmAsia News
Executive Summary
Hong Kong's pharmaceutical industry believes it is in a position to attract clinical trials by foreign companies, particularly those interested in marketing to mainland China.